| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 48.298 | 57.715 | 49.738 | 16.601 | 20.460 | 7.942 | 9.210 | 122.414 | 229.545 | 276.793 |
| Total Income - EUR | 48.543 | 57.726 | 50.032 | 16.601 | 20.460 | 9.586 | 9.748 | 122.598 | 231.426 | 280.005 |
| Total Expenses - EUR | 21.080 | 25.370 | 25.935 | 17.491 | 17.119 | 9.651 | 9.267 | 37.651 | 95.480 | 125.812 |
| Gross Profit/Loss - EUR | 27.463 | 32.356 | 24.097 | -889 | 3.341 | -65 | 481 | 84.946 | 135.946 | 154.193 |
| Net Profit/Loss - EUR | 26.006 | 31.779 | 23.597 | -1.055 | 3.137 | -145 | 389 | 83.722 | 133.980 | 147.309 |
| Employees | 3 | 3 | 4 | 2 | 1 | 1 | 1 | 3 | 6 | 7 |
Check the financial reports for the company - Masajmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 1.309 | 831 | 405 | 1.849 | 4.345 | 6.082 |
| Current Assets | 51.545 | 34.090 | 51.256 | 19.346 | 9.566 | 7.270 | 12.444 | 50.430 | 164.207 | 296.300 |
| Inventories | 598 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 5.527 | 4.737 | 4.387 | 3.106 | 3.323 | 1.670 | 3.200 | 16.297 | 29.622 | 30.385 |
| Cash | 27.177 | 29.353 | 46.869 | 16.240 | 6.243 | 5.600 | 9.245 | 34.132 | 134.585 | 265.916 |
| Shareholders Funds | 50.360 | 31.832 | 23.650 | 15.781 | 7.965 | 7.669 | 7.888 | 24.687 | 152.000 | 284.037 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.185 | 2.258 | 27.660 | 3.564 | 2.911 | 432 | 4.961 | 27.592 | 16.552 | 18.345 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8695 - 8695" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Masajmed Srl